Macro trends in pharmaceutical innovation.
Critics decry the lack of 'truly innovative' new medicines and question the role of the pharmaceutical industry in creating the few that are developed. Is this an accurate portrayal of the state of pharmaceutical innovation? Does major pharma still innovate? If so, how? Must the industry innovate to survive? These and related issues are discussed.
Cohen
Fredric J
FJ
Crownstone, 3331 Street Road, Suite 140, Bensalem, Pennsylvania 19020, USA. fred@crownstonegroup.com
D002986:Clinical Trials as Topic / Q000145:classification; D004345:Drug Industry / Q000191:economics / Q000379:methods / Q000639:trends*; D006801:Humans; D009316:National Institutes of Health (U.S.); D009936:Organizational Innovation; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis / Q000145:classification / Q000191:economics; D018581:Technology Transfer; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations